Mathew Coleman

Has grant

Professor

University of Birmingham
Country flagUnited Kingdom

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Mathew Coleman is a Professor at the University of Birmingham, UK. His research primarily focuses on the biochemical mechanisms involving oxygenases, GTPases, and their roles in various diseases, particularly in relation to neurodevelopmental disorders and hypoxia. Recent publications include studies on pyridine derivatives and their potential in protein inhibition, as well as the modulation of HIF prolyl hydroxylases for cardioprotection. His work contributes to a deeper understanding of protein function and the impact of metabolic stress on developmental processes.

Recent Grants

Grant: Close

Investigating the role of protein hydroxylation in cancer

Open Date: 2017-10-01

Close Date: 2023-09-30

Grant: Close

Assigning the hydroxylase activity of the breast cancer-associated Lysine Demethylase 8 (KDM8)

Open Date: 2016-11-01

Close Date: 2017-05-03

Grant: Close

Defining a protein hydroxylase tumour suppressor pathway

Open Date: 2016-06-01

Close Date: 2019-05-01

Grant: Close

Characterisation of a kinase-hydroxylase signaling pathway that is alterated in cognitive impairment disorders and cancer

Open Date: 2015-10-01

Close Date: 2016-09-01

Grant: Close

Investigating the role of Jmjd4 in tumourigenesis

Open Date: 2013-01-01

Close Date: 2017-01-01

Articles (9)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (4)

Lorenzo Antonini

Sapienza University of Rome

ITALY
View details

Giorgia Fiorini

Paul Scherrer Institut

SWITZERLAND
View details

Peter Ratcliffe

University of Oxford

UNITED KINGDOM
View details

Lennart Brewitz

University of Oxford

UNITED KINGDOM
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.